326 related articles for article (PubMed ID: 30520526)
21. Lymphomatoid Papulosis With T-cell Receptor-Gamma Delta Expression: A Clinicopathologic Case-series of 26 Patients of an Underrecognized Immunophenotypic Variant of Lymphomatoid Papulosis.
Mark E; Kempf W; Guitart J; Pulitzer M; Mitteldorf C; Hristov A; Torres-Cabala C; Marchi E; Cropley T; Rodriguez Pinilla SM; Griffin T; Fernandez R; Pileri S; Pileri A; Tabanelli V; Borretta L; Subtil A; Plaza JA; Piris JAMA; Feldman AL; Cerroni L; Gru AA
Am J Surg Pathol; 2024 May; 48(5):501-510. PubMed ID: 38533681
[TBL] [Abstract][Full Text] [Related]
22. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin.
DeCoteau JF; Butmarc JR; Kinney MC; Kadin ME
Blood; 1996 Apr; 87(8):3437-41. PubMed ID: 8605362
[TBL] [Abstract][Full Text] [Related]
23. Fascin expression in CD30-positive cutaneous lymphoproliferative disorders.
Kempf W; Levi E; Kamarashev J; Kutzner H; Pfeifer W; Petrogiannis-Haliotis T; Burg G; Kadin ME
J Cutan Pathol; 2002 May; 29(5):295-300. PubMed ID: 12100631
[TBL] [Abstract][Full Text] [Related]
24. Lymphomatoid papulosis and anaplastic large cell lymphomas of the skin.
Drews R; Samel A; Kadin ME
Semin Cutan Med Surg; 2000 Jun; 19(2):109-17. PubMed ID: 10892712
[TBL] [Abstract][Full Text] [Related]
25. Expression of cutaneous lymphocyte-associated antigen and TIA-1 by lymphocytes in pityriasis lichenoides et varioliformis acuta and lymphomatoid papulosis: immunohistochemical study.
Jang KA; Choi JC; Choi JH
J Cutan Pathol; 2001 Oct; 28(9):453-9. PubMed ID: 11553311
[TBL] [Abstract][Full Text] [Related]
26. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.
Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M
Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894
[TBL] [Abstract][Full Text] [Related]
27. Galectin-3 Expression in Primary Cutaneous CD30-Positive Lymphoproliferative Disorders and Transformed Mycosis Fungoides.
Mitteldorf C; Robson A; Tronnier M; Pfaltz MC; Kempf W
Dermatology; 2015; 231(2):164-70. PubMed ID: 26111483
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders.
Benner MF; Jansen PM; Meijer CJ; Willemze R
Br J Dermatol; 2009 Jul; 161(1):121-7. PubMed ID: 19416236
[TBL] [Abstract][Full Text] [Related]
29. Mycosis Fungoides Associated With Lesions in the Spectrum of Primary Cutaneous CD30+ Lymphoproliferative Disorders: The Same Process or 3 Coexisting Lymphomas?
Cieza-Díaz DE; Prieto-Torres L; Rodríguez-Pinilla SM; Córdoba Mascuñano R; Manso Alonso R; Machan S; Piris Pinilla MÁ; Requena Caballero L
Am J Dermatopathol; 2019 Nov; 41(11):846-850. PubMed ID: 30946099
[TBL] [Abstract][Full Text] [Related]
30. IL-4 production by CD8+ lymphomatoid papulosis, type C, attracts background eosinophils.
Slone SP; Martin AW; Wellhausen SR; Woods DR; Malone JC; Lear SC; Laber DA
J Cutan Pathol; 2008 Oct; 35 Suppl 1():38-45. PubMed ID: 18537857
[TBL] [Abstract][Full Text] [Related]
31. Type B follicular lymphomatoid papulosis.
Chaudhari PR; Emanuel P; Levitt J
Cutis; 2010 Jun; 85(6):307-11. PubMed ID: 20666192
[TBL] [Abstract][Full Text] [Related]
32. CD30+ lymphoproliferative disorder with spindle-cell morphology.
Martires KJ; Cohen BE; Cassarino DS
J Cutan Pathol; 2016 Nov; 43(11):1041-1044. PubMed ID: 27433975
[TBL] [Abstract][Full Text] [Related]
33. Three cases of lymphomatoid papulosis with a CD56+ immunophenotype.
Flann S; Orchard GE; Wain EM; Russell-Jones R
J Am Acad Dermatol; 2006 Nov; 55(5):903-6. PubMed ID: 17052504
[TBL] [Abstract][Full Text] [Related]
34. Lymphomatoid papulosis in association with mycosis fungoides: a study of 15 cases.
Basarab T; Fraser-Andrews EA; Orchard G; Whittaker S; Russel-Jones R
Br J Dermatol; 1998 Oct; 139(4):630-8. PubMed ID: 10025972
[TBL] [Abstract][Full Text] [Related]
35. The pathology of cutaneous T-cell lymphoma.
Robson A
Oncology (Williston Park); 2007 Feb; 21(2 Suppl 1):9-12. PubMed ID: 17474353
[TBL] [Abstract][Full Text] [Related]
36. Follicular lymphomatoid papulosis revisited: a study of 11 cases, with new histopathological findings.
Kempf W; Kazakov DV; Baumgartner HP; Kutzner H
J Am Acad Dermatol; 2013 May; 68(5):809-16. PubMed ID: 23375516
[TBL] [Abstract][Full Text] [Related]
37. Th2 cytokine mRNA expression in primary cutaneous CD30-positive lymphoproliferative disorders: successful treatment with recombinant interferon-gamma.
Yagi H; Tokura Y; Furukawa F; Takigawa M
J Invest Dermatol; 1996 Dec; 107(6):827-32. PubMed ID: 8941669
[TBL] [Abstract][Full Text] [Related]
38. Lymphomatoid papulosis and cutaneous CD30+ lymphoma.
LeBoit PE
Am J Dermatopathol; 1996 Jun; 18(3):221-35. PubMed ID: 8806956
[TBL] [Abstract][Full Text] [Related]
39. Lymphomatoid papulosis with folliculotropism, eccrinotropism and neurotropism.
Ba W; Yang Y; Zhang Z; Wei X; Wang W; Zhao Z; Zheng L; Li C
J Cutan Pathol; 2018 Jul; 45(7):530-534. PubMed ID: 29660166
[TBL] [Abstract][Full Text] [Related]
40. Contribution of longitudinal follow up and clinical pathological correlation in the diagnosis CD30-positive skin infiltrates.
De Souza A; Carter JB; Harris NL; Ferry JA; Duncan LM
J Cutan Pathol; 2015 Jul; 42(7):452-8. PubMed ID: 25931140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
